
Antibodies Assay Kits Bap1 Antibody Biology Cells Brd4 Antibody Canine Albumin cDNA Culture Cells Devices Glut2 Antibody Gsk3 Alpha Hama Antibodies Medium & Serums Muc2 Antibody NATtrol Nedd4 Antibody Nox1 Antibody PCR Reagents Recombinant Proteins Ria Kits RNA Tgf Alpha Elisa Vector & Virus Vi Alpha Vitronectin Antibody Western Blot Zebrafish Antibodies
Human-SARS-CoV-2 interactome and human genetic diversity: TMPRSS2-rs2070788, associated with severe influenza, and its population genetics caveats in Native Americans
For human/SARS-CoV-2 interactome genes ACE2, TMPRSS2 and BSG, there’s a convincing proof of affiliation in Asians with influenza-induced SARS for TMPRSS2-rs2070788, tag-SNP of the eQTL rs383510. This case illustrates the significance of inhabitants genetics and of sequencing knowledge within the design of genetic affiliation research in several human populations: the excessive linkage disequilibrium (LD) between rs2070788 and rs383510 is Asian-specific.
Leveraging on a mixture of genotyping and sequencing knowledge for Native Individuals (uncared for in genetic research), we present that whereas their frequencies of the Asian tag-SNP rs2070788 is, surprisingly, the best worldwide, it isn’t in LD with the eQTL rs383510, that subsequently, must be straight genotyped in genetic affiliation research of SARS in populations with Native American ancestry.
PRICKLE1 × FOCAD Interplay Revealed by Genome-Broad vQTL Evaluation of Human Facial Traits
The human face is a extremely advanced and variable construction ensuing from the intricate coordination of quite a few genetic and non-genetic elements. A whole bunch of genomic loci impacting quantitative facial options have been recognized.
Whereas these associations have been proven to affect morphology by altering the imply dimension and form of facial measures, their impact on trait variance stays unclear. We carried out a genome-wide affiliation evaluation for the variance of 20 quantitative facial measurements in 2,447 European people and recognized a number of suggestive variance quantitative trait loci (vQTLs).
These vQTLs guided us to conduct an environment friendly seek for gene-by-gene (G × G) interactions, which uncovered an interplay between PRICKLE1 and FOCAD affecting cranial base width. We replicated this G × G interplay sign on the locus stage in an extra 5,128 Korean people.
We used the hypomorphic Prickle1 Beetlejuice (Prickle1 Bj ) mouse line to straight take a look at the perform of Prickle1 on the cranial base and noticed wider cranial bases in Prickle1 Bj/Bj . Importantly, we noticed that the Prickle1 and Focadhesin proteins co-localize in murine cranial base chondrocytes, and this co-localization is irregular within the Prickle1 Bj/Bj mutants.
Taken collectively, our findings uncovered a novel G × G interplay impact in people with robust help from each epidemiological and molecular research. These outcomes spotlight the potential of finding out measures of phenotypic variability in gene mapping research of facial morphology.
Proof for opposing selective forces working on human-specific duplicated TCAF genes in Neanderthals and people
TRP channel-associated issue half (TCAF1/TCAF2) proteins antagonistically regulate the cold-sensor protein TRPM8 in a number of human tissues. Understanding their significance has been difficult given the locus spans a gap-ridden area with advanced segmental duplications in GRCh38. Utilizing long-read sequencing, we sequence-resolve the locus, annotate full-length TCAF fashions in primate genomes, and present substantial human-specific TCAF copy quantity variation.
We determine two human tremendous haplogroups, H4 and H5, and set up that TCAF duplications originated ~1.7 million years in the past however diversified solely in Homo sapiens by recurrent structural mutations. Conversely, in all archaic-hominin samples the fixation for a particular H4 haplotype with out duplication is probably going on account of constructive choice.
Right here, our outcomes of TCAF copy quantity enlargement, choice alerts in hominins, and differential TCAF2 expression between haplogroups and excessive TCAF2 and TRPM8 expression in liver and prostate in modern-day people suggest TCAF diversification amongst hominins doubtlessly in response to chilly or dietary diversifications.
A world map of associations between varieties of protein posttranslational modifications and human genetic ailments
There are >200 varieties of protein posttranslational modifications (PTMs) described in eukaryotes, every with distinctive proteome protection and capabilities. We hypothesized that some genetic ailments could also be attributable to the removing of a particular kind of PTMs by genomic variants and the resultant deregulation of explicit capabilities.
We collected >320,000 human PTMs representing 59 varieties and crossed them with >4M nonsynonymous DNA variants annotated with predicted pathogenicity and illness associations. We report >1.74M PTM-variant co-occurrences that an enrichment evaluation distributed into 215 pairwise associations between 18 PTM varieties and 148 genetic ailments.
Of them, 42% weren’t beforehand described. Elimination of lysine acetylation exerts probably the most pronounced impact, and fewer studied PTM varieties equivalent to S-glutathionylation or S-nitrosylation present relevance. Utilizing pathogenicity predictions, we recognized PTM websites that will produce explicit ailments if prevented. Our outcomes present proof of a considerable affect of PTM-specific removing on the pathogenesis of genetic ailments and phenotypes.
Human Codon Utilization: The Genetic Foundation of Pathogen Latency
Infectious ailments pose two important compelling points. First, the identification of the molecular elements that enable continual infections, that’s, the customarily fully asymptomatic coexistence of infectious brokers with the human host. Second, the definition of the mechanisms that enable the swap from pathogen dormancy to pathologic (re)activation.
Furthering earlier research, the current examine (1) analyzed the frequency of prevalence of synonymous codons in coding DNA, that’s, codon utilization, as a genetic device that guidelines protein expression; (2) described how human codon utilization can inhibit protein expression of infectious brokers throughout latency, in order that pathogen genes the codon utilization of which doesn’t conform to the human codon utilization can’t be translated; and (3) framed human codon utilization among the many front-line devices of the innate immunity towards infections.
In parallel, it was proven that, whereas genetics can account for the molecular foundation of pathogen latency, the modifications of the quantitative relationship between codon frequencies and isoaccepting tRNAs throughout cell proliferation supply a biochemical mechanism that explains the pathogen switching to (re)activation. Immunologically, this examine warns that utilizing codon optimization methodologies can (re)activate, potentiate, and immortalize in any other case quiescent, asymptomatic pathogens, thus resulting in uncontrollable pandemics.
Engineered human induced pluripotent cells allow genetic code enlargement in mind organoids
Human induced pluripotent stem cell (hiPSC) expertise has revolutionized human biology. A variety of cell varieties and tissue fashions will be derived from hiPSCs to review advanced human ailments. Right here, we use PiggyBac mediated transgenesis to engineer hiPSCs with an expanded genetic code. We reveal that genomic integration of expression cassettes for a pyrrolysyl-tRNA synthetase (PylRS), pyrrolysyl-tRNA (PylT) and the goal protein of curiosity permits site-specific incorporation of a non-canonical amino acid (ncAA) in response to amber cease codons.
West Nile Virus Envelope Peptide |
|||
3437P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) West Nile Virus Envelope peptide |
West Nile Virus Envelope Antibody |
|||
3439-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Envelope Antibody |
|||
3439-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Envelope Peptide |
|||
3439P | ProSci | 0.05 mg | EUR 197.7 |
Description: (NT) West Nile Virus Envelope peptide |
West Nile Virus Envelope Antibody |
|||
3441-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Envelope Antibody |
|||
3441-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Envelope Peptide |
|||
3441P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) West Nile Virus Envelope peptide |
West Nile Virus Envelope Protein |
|||
abx060680-100ug | Abbexa | 100 ug | EUR 794.4 |
West Nile Envelope Virus Protein |
|||
20-abx260322 | Abbexa |
|
|
West Nile Virus Envelope Recombinant Protein |
|||
53-361 | ProSci | 0.01 mg | EUR 714.3 |
Description: West Nile Virus Envelope Recombinant Protein |
West Nile Virus Envelope recombinant antigen |
|||
00401-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: West Nile Virus Envelope recombinant antigen-Immunodominant region |
West Nile Virus Envelope recombinant antigen |
|||
00401-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: West Nile Virus Envelope recombinant antigen-Immunodominant region |
West Nile Virus Envelope Protein Antibody |
|||
abx022312-1mg | Abbexa | 1 mg | EUR 1296 |
West Nile Virus Envelope Protein Antibody |
|||
abx022314-1mg | Abbexa | 1 mg | EUR 1228.8 |
West Nile Virus Envelope Protein Antibody |
|||
abx022315-1mg | Abbexa | 1 mg | EUR 1296 |
West Nile Virus Envelope Protein Antibody |
|||
abx022316-1mg | Abbexa | 1 mg | EUR 1296 |
West Nile Virus Envelope recombinant antigen |
|||
8822 | Virostat | 100 ug | EUR 529.8 |
Description: This is West Nile Virus Envelope recombinant antigen for ELISA,WB. |
Polyclonal West Nile Virus Envelope Antibody |
|||
APR11226G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
Polyclonal West Nile Virus Envelope Antibody |
|||
AMM05448G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
Polyclonal West Nile Virus Envelope Antibody |
|||
AMM05449G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Envelope . This antibody is tested and proven to work in the following applications: |
Recombinant West Nile Virus Envelope Protein |
|||
P1065-10 | Biovision | each | EUR 189.6 |
Recombinant West Nile Virus Envelope Protein |
|||
P1065-50 | Biovision | each | EUR 366 |
Mouse antibody for West Nile Virus Envelope |
|||
3655 | Virostat | 100 ug | EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
Mouse antibody for West Nile Virus Envelope |
|||
3661 | Virostat | 100 ug | EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
Mouse antibody for West Nile Virus Envelope |
|||
3671 | Virostat | 100 ug | EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against West Nile Virus Envelope for WB, ELISA. |
West Nile virus antibody |
|||
10-1436 | Fitzgerald | 100 ug | EUR 489.6 |
Description: Mouse monoclonal West Nile virus antibody |
West Nile virus antibody |
|||
10-1437 | Fitzgerald | 100 ug | EUR 489.6 |
Description: Mouse monoclonal West Nile virus antibody |
Virus West Nile Virus (WNV) Protein |
|||
abx670276-100ug | Abbexa | 100 ug | EUR 794.4 |
Native West Nile Virus antigen |
|||
DAGA-3052 | Creative Diagnostics | 1mg | EUR 1279.2 |
Native West Nile Virus antigen |
|||
DAGA-3053 | Creative Diagnostics | 1mg | EUR 1279.2 |
West Nile Virus Matrix Antibody |
|||
24278-100ul | SAB | 100ul | EUR 468 |
West Nile Virus Matrix Antibody |
|||
24279-100ul | SAB | 100ul | EUR 468 |
West Nile Virus Core Antibody |
|||
24281-100ul | SAB | 100ul | EUR 468 |
West Nile Virus Matrix Antibody |
|||
3429-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Matrix Antibody |
|||
3429-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Matrix Peptide |
|||
3429P | ProSci | 0.05 mg | EUR 197.7 |
Description: (IN) West Nile Virus Matrix peptide |
West Nile Virus Matrix Antibody |
|||
3431-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Matrix Antibody |
|||
3431-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
West Nile Virus Matrix Peptide |
|||
3431P | ProSci | 0.05 mg | EUR 197.7 |
Description: (CT) West Nile Virus Matrix peptide |
West Nile Virus Core Antibody |
|||
3435-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: West Nile Virus Core Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation. |
West Nile Virus Core Antibody |
|||
3435-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: West Nile Virus Core Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation. |
West Nile Virus Core Peptide |
|||
3435P | ProSci | 0.05 mg | EUR 197.7 |
Description: (CT) West Nile Virus Core peptide |
West Nile virus protein (Horse) |
|||
30-1261 | Fitzgerald | 250 ug | EUR 548.4 |
Description: Purified recombinant West Nile virus protein (Horse) |
West Nile Virus (WNV) Antibody |
|||
abx412023-01mg | Abbexa | 0.1 mg | EUR 610.8 |
West Nile Virus NS1 protein |
|||
80-1546 | Fitzgerald | 100 ug | EUR 541.2 |
Description: Purified Recombinant West Nile Virus NS1 protein (His tag) |
West nile virus PCR kit |
|||
PCR-VH054-48R | Bioingentech | 50T | EUR 987.6 |
West nile virus PCR kit |
|||
PCR-VH054-96R | Bioingentech | 100T | EUR 1335.6 |
Recombinant West Nile Virus Envelope Protein (N-terminus), His-tagged |
|||
DAG566 | Creative Diagnostics | 100ug | EUR 786 |
Recombinant West Nile Virus WNV Envelope Protein, His, E.coli-100ug |
|||
QP13964-100ug | EnQuireBio | 100ug | EUR 261.6 |
Recombinant West Nile Virus WNV Envelope Protein, His, E.coli-1mg |
|||
QP13964-1mg | EnQuireBio | 1mg | EUR 1513.2 |
Recombinant West Nile Virus WNV Envelope Protein, His, E.coli-500ug |
|||
QP13964-500ug | EnQuireBio | 500ug | EUR 795.6 |
Recombinant West Nile Pre-M Virus |
|||
7-07963 | CHI Scientific | 100µg | Ask for price |
Recombinant West Nile Pre-M Virus |
|||
7-07964 | CHI Scientific | 500µg | Ask for price |
Recombinant West Nile Pre-M Virus |
|||
7-07965 | CHI Scientific | 1000µg | Ask for price |
West Nile Virus ENV recombinant antigen |
|||
00403-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: West Nile Virus Envelope full length recombinant antigen 42 kDa region |
West Nile Virus ENV recombinant antigen |
|||
00403-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: West Nile Virus Envelope full length recombinant antigen 42 kDa region |
West Nile Virus Core Protein Antibody |
|||
abx023202-100ug | Abbexa | 100 ug | EUR 811.2 |
West Nile Virus Pre-M Protein |
|||
abx060681-100ug | Abbexa | 100 ug | EUR 794.4 |
West Nile Pre-M Virus Protein |
|||
20-abx260323 | Abbexa |
|
|
Polyclonal West Nile Virus Matrix Antibody |
|||
APR11227G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Matrix . This antibody is tested and proven to work in the following applications: |
Polyclonal West Nile Virus Core Antibody |
|||
AMM05447G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Core . This antibody is tested and proven to work in the following applications: |
Polyclonal West Nile Virus Matrix Antibody |
|||
AMM05450G | Leading Biology | 0.1 mg | EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human West Nile Virus Matrix . This antibody is tested and proven to work in the following applications: |
West nile virus RT PCR kit |
|||
RTq-VH054-100R | Bioingentech | 100T | EUR 1573.2 |
West nile virus RT PCR kit |
|||
RTq-VH054-150R | Bioingentech | 150T | EUR 2144.4 |
West nile virus RT PCR kit |
|||
RTq-VH054-50R | Bioingentech | 50T | EUR 1155.6 |
QPCR Kit RNA West Nile virus |
|||
MOL6366 | Scientific Laboratory Supplies | EACH | EUR 839.04 |
West Nile Virus Pre-M recombinant antigen |
|||
00402-V-01mg | Virogen | 0,1 mg | EUR 321 |
Description: West Nile Virus Pre-M recombinant antigen-Immunodominant region |
West Nile Virus Pre-M recombinant antigen |
|||
00402-V-1000ug | Virogen | 1000 ug | EUR 1539 |
Description: West Nile Virus Pre-M recombinant antigen-Immunodominant region |
West Nile Virus E protein (His tag) |
|||
80-1339 | Fitzgerald | 100 ug | EUR 289.2 |
Description: Purified recombinant West Nile Virus E protein (His tag) |
West nile virus One-Step PCR kit |
|||
Oneq-VH054-100R | Bioingentech | 100T | EUR 1932 |
West nile virus One-Step PCR kit |
|||
Oneq-VH054-150R | Bioingentech | 150T | EUR 2646 |
West nile virus One-Step PCR kit |
|||
Oneq-VH054-50R | Bioingentech | 50T | EUR 1410 |
West Nile virus (WNV) Protein Detection Set |
|||
PSI-1809 | ProSci | 1 Set | EUR 884.4 |
Description: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M” protein to its mature form occurs during release of the virus; this cleavage leads to the dissociation of the heterodimers. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation. The highly glycosylated envelope protein was shown to play a major role for WNV entry into target cells as WNV entry was inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin.;;For images please see PDF data sheet |
Human West nile virus IgM (WNV-IgM) ELISA Kit |
|||
abx055291-96tests | Abbexa | 96 tests | EUR 801.6 |
Human West nile virus IgG (WNV-IgG) ELISA Kit |
|||
abx055292-96tests | Abbexa | 96 tests | EUR 801.6 |
Rabbit Anti-West Nile Virus (WNV) envelop protein antiserum |
|||
WNV16-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-West Nile Virus Env-DIII protein antiserum |
|||
WNVE19-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-West Nile Virus prM (WNV-prM) antiserum |
|||
WNVP21-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
SeroDetect West Nile Virus Verification Panel (10 X 0.5 mL) |
|||
KZMC027 | Zeptometrix | 10 X 0.5 mL | EUR 334.56 |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
Rabbit Anti-West Nile Virus (WNV vaccine/Innovator, inactivated) antiserum |
|||
WNV12-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-West Nile Virus prm (WNV-prM) protein antiserum |
|||
WNV18-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Mouse Monoclonal Anti-West Nile Virus NS1 (WNV-NS1) IgG |
|||
WNVN20-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Recombinant (E. coli) West Nile N-terminus Envelope Virus (WNV) (E. Coli, >95%, 42 Kda, his-tag) |
|||
RP-1456 | Alpha Diagnostics | 50 ug | EUR 343.2 |
Mouse Anti-West Nile Virus (whole virus) IgG ELISA kit, 2x96 tests, Quantitative |
|||
910-200-WNM | Alpha Diagnostics | 1 Kit | EUR 1951.2 |
Mouse Anti-West Nile Virus (whole virus) IgM ELISA kit, 2x96 tests, Quantitative |
|||
910-205-WNM | Alpha Diagnostics | 1 Kit | EUR 1000.8 |
Human Anti-West Nile Virus (whole virus) IgG ELISA kit, 96 tests, qualitative |
|||
910-400-WVG | Alpha Diagnostics | 1 Kit | EUR 854.4 |
Human Anti-West Nile Virus (whole virus) IgM ELISA kit, 96 tests, qualitative |
|||
910-405-WVG | Alpha Diagnostics | 1 Kit | EUR 854.4 |
Recombinant West Nile Virus Pre-M Protein (N-terminal), His-tagged |
|||
DAG584 | Creative Diagnostics | 100ug | EUR 786 |
ELISA kit for Human West Nile virus IgG (WNV IgG) Kit |
|||
KTE62976-48T | Abbkine | 48T | EUR 424.8 |
Description: Quantitative sandwich ELISA for measuring Human West Nile virus IgG (WNV IgG) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human West Nile virus IgG (WNV IgG) Kit |
|||
KTE62976-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2702.4 |
Description: Quantitative sandwich ELISA for measuring Human West Nile virus IgG (WNV IgG) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human West Nile virus IgG (WNV IgG) Kit |
|||
KTE62976-96T | Abbkine | 96T | EUR 686.4 |
Description: Quantitative sandwich ELISA for measuring Human West Nile virus IgG (WNV IgG) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human West Nile virus IgM (WNV IgM) Kit |
|||
KTE62977-48T | Abbkine | 48T | EUR 424.8 |
Description: Quantitative sandwich ELISA for measuring Human West Nile virus IgM (WNV IgM) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human West Nile virus IgM (WNV IgM) Kit |
|||
KTE62977-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2702.4 |
Description: Quantitative sandwich ELISA for measuring Human West Nile virus IgM (WNV IgM) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human West Nile virus IgM (WNV IgM) Kit |
|||
KTE62977-96T | Abbkine | 96T | EUR 686.4 |
Description: Quantitative sandwich ELISA for measuring Human West Nile virus IgM (WNV IgM) Kit in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
Recombinant West Nile Virus WNV Pre-M Protein, His, E.coli-100ug |
|||
QP13965-100ug | EnQuireBio | 100ug | EUR 261.6 |
Recombinant West Nile Virus WNV Pre-M Protein, His, E.coli-1mg |
|||
QP13965-1mg | EnQuireBio | 1mg | EUR 1513.2 |
Recombinant West Nile Virus WNV Pre-M Protein, His, E.coli-500ug |
|||
QP13965-500ug | EnQuireBio | 500ug | EUR 795.6 |
Rabbit Anti-West Nile Virus vaccine (WNV, Recombitek/DNA vaccine) antiserum |
|||
WNV13-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-West Nile Virus NS1 (WNV-NS1, US strain) protein antiserum |
|||
WNV17-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Mouse Anti-West Nile Virus (WNV-whole virus) IgG ELISA kit, 2x96 tests, Semi-Quantitative |
|||
910-200-WNG | Alpha Diagnostics | 1 Kit | EUR 1951.2 |
Human Anti-West Nile Virus (WNV-whole virus) IgG ELISA kit, 96 tests, Semi-Quantitative |
|||
910-300-WNG | Alpha Diagnostics | 1 Kit | EUR 1000.8 |
Human Anti-West Nile Virus (WNV-whole virus) IgM ELISA kit, 96 tests, Semi-Quantitative |
|||
910-305-WNM | Alpha Diagnostics | 1 Kit | EUR 1000.8 |
Monkey Anti-West Nile Virus (WNV-whole virus) IgG ELISA kit, 2x96 tests, Semi-Quantitative |
|||
910-400-WNG | Alpha Diagnostics | 1 Kit | EUR 1951.2 |
Monkey Anti-West Nile Virus (WNV-whole virus) IgM ELISA kit, 2x96 tests, Semi-Quantitative |
|||
910-405-WNM | Alpha Diagnostics | 1 Kit | EUR 1951.2 |
West Nile Virus NS1 Protein (WNV-NS1) antigen ELISA kit, 96 tests, Quantitative |
|||
910-290-NS1 | Alpha Diagnostics | 1 Kit | EUR 1000.8 |
Recombinant West Nile Virus (WNV) Pre-M Virus (E. Coli, ~20 Kda, >95%, his-tag) protein |
|||
RP-1457 | Alpha Diagnostics | 50 ug | EUR 343.2 |
Zika virus envelope protein |
|||
30-1932 | Fitzgerald | 100 ug | EUR 457.2 |
Description: Recombinant Zika virus envelope protein |
Zika virus envelope protein |
|||
30-1935 | Fitzgerald | 100 ug | EUR 289.2 |
Description: Recombinant Zika virus envelope protein |
Zika virus envelope antibody |
|||
10-2712 | Fitzgerald | 1 mg | EUR 678 |
Description: Mouse monoclonal Zika virus envelope antibody |
Zika virus envelope antibody |
|||
10-2713 | Fitzgerald | 1 mg | EUR 678 |
Description: Mouse monoclonal Zika virus envelope antibody |
Zika virus envelope antibody |
|||
10-2714 | Fitzgerald | 1 mg | EUR 678 |
Description: Mouse monoclonal Zika virus envelope antibody |
Zika virus envelope antibody |
|||
10-2715 | Fitzgerald | 1 mg | EUR 678 |
Description: Mouse monoclonal Zika virus envelope antibody |
Zika Virus Envelope Protein |
|||
abx160022-1mg | Abbexa | 1 mg | EUR 1746 |
Zika Virus Envelope Protein |
|||
abx061381-1mg | Abbexa | 1 mg | EUR 1722 |
Chikungunya Virus Envelope Antibody |
|||
abx024072-1mg | Abbexa | 1 mg | EUR 1161.6 |
Chikungunya Virus Envelope Antibody |
|||
abx024073-1mg | Abbexa | 1 mg | EUR 1161.6 |
Chikungunya Virus Envelope Antibody |
|||
abx024074-1mg | Abbexa | 1 mg | EUR 1161.6 |
Chikungunya Virus Envelope Antibody |
|||
abx024075-1mg | Abbexa | 1 mg | EUR 1161.6 |
Chikungunya Virus Envelope Antibody |
|||
abx024076-1mg | Abbexa | 1 mg | EUR 1161.6 |
Zika Virus Envelope Antibody |
|||
abx024128-1mg | Abbexa | 1 mg | EUR 1730.4 |
Zika Virus Envelope Antibody |
|||
abx024129-1mg | Abbexa | 1 mg | EUR 1730.4 |
Zika Virus Envelope Antibody |
|||
abx024130-1mg | Abbexa | 1 mg | EUR 1730.4 |
Zika Virus Envelope Antibody |
|||
abx024131-1mg | Abbexa | 1 mg | EUR 1730.4 |
Zika Virus Envelope Antibody |
|||
abx024132-1mg | Abbexa | 1 mg | EUR 1696.8 |
Zika Virus Envelope Antibody |
|||
abx024133-1mg | Abbexa | 1 mg | EUR 1696.8 |
NATtrol West Nile Virus (WNV) Strain: NY 2001-6263 (50,000 cp/mL) (1 mL) |
|||
NATWNV-0001 | Zeptometrix | 50,000 cp/mL 1 mL | EUR 103.68 |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
NATtrol West Nile Virus (WNV) Strain: NY 2001-6263 (500 cp/mL) (1 mL) |
|||
NATWNV-0002 | Zeptometrix | 500 cp/mL 1 mL | EUR 148.61 |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
NATtrol West Nile Virus (WNV) Strain: NY 2001-6263 (1,000 cp/mL) (1 mL) |
|||
NATWNV-0003 | Zeptometrix | 1,000 cp/mL 1 mL | EUR 213.5 |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
NATtrol West Nile Virus (WNV) Strain: NY 2001-6263 (10,000 cp/mL) (1 mL) |
|||
NATWNV-0004 | Zeptometrix | 10,000 cp/mL 1 mL | EUR 344.54 |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
NATtrol West Nile Virus (WNV) Strain: NY 2001-6263 (50,000 cp/mL) (1 mL) |
|||
NATWNV-0005 | Zeptometrix | 50,000 cp/mL 1 mL | EUR 549.22 |
Description: Please contact Gentaur in order to receive the datasheet of the product. |
Recombinant (HEK) West Nile Virus NS1 (WNV-NS1) protein (>95%, ~50 Kda, His-tag) |
|||
WNVNS21-R-50 | Alpha Diagnostics | 50 ug | EUR 489.6 |
West Nile Virus (WNV) (Strain: NY 2001-6263) Culture Fluid (Heat Inactivated) (1 mL) |
|||
0810033CFHI | Zeptometrix | - | EUR 422 |
West Nile Virus (WNV) Lineage 2 (Strain: 1986) Culture Fluid (Heat Inactivated) (1 mL) |
|||
0810082CFHI | Zeptometrix | - | EUR 422 |
×
Neural stem cells, neurons and mind organoids derived from the engineered hiPSCs proceed to precise the amber suppression equipment and produce ncAA-bearing reporter. The integrated ncAA can function a minimal bioorthogonal deal with for additional modifications by labeling with fluorescent dyes. Website-directed ncAA mutagenesis will open a variety of functions to probe and manipulate proteins in mind organoids and different hiPSC-derived cell varieties and complicated tissue fashions.
Tags: anti ki67 antibody labeling biotin lysine bl21 de3 cells bsa western blot dicer antibody empty chromatography column exosome isolation kit fetal bovine serum gk1 5 gli2 antibody human egf immunoprecipitation protocol magnetic beads kinase assay kit mouse igg isotype control mouse igg1 isotype control p40 antibody phalloidin 568 qpcr 96 well plate qubit dna concentration qubit hs rbc lysis buffer recipe renilla luciferase assay rt pcr kits satb2 antibody sirna transfection protocol streptavidin antibodies streptavidin magnetic beads superscript ii reverse transcriptase tbk1 antibody testosterone elisa traf6 antibody western blotting kits